As he finishes his 6-year tenure with the Ky lab this month, we would like to highlight the work of Dr. Biniyam Demissei and his research focusing on #breastcancer and Cardiovascular function: https://t.co/a7IWIrIrz7 #BreastCancerAwarenessMonth #CardioOnc
Our work on the potential impact of BRCA1/2 mutations on cardiovascular function following doxorubicin exposure in breast cancer survivors is out @FrontCVMedicine https://t.co/I8QMMgjVZk
RT @FrontCVMedicine: New Research: BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors: Objective Animal models sugge…
New Research: BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors: Objective Animal models suggest that BRCA1/2 mutations increase doxorubicin-induced cardiotoxicity risk but data in humans are limited. We aimed to… https://t.co/QNwiX